For patients with severe blockages in the coronary arteries, lifestyle changes may not be enough to restore normal blood flow to the heart. One common treatment—coronary artery bypass surgery—is safer than ever thanks to advances in robotics. At the Lankenau Heart Institute, we’re performing minimally-invasive cardiac surgery using the most advanced surgical robots. This approach requires a one and a quarter-inch incision instead of the usual eight-inch incision used during traditional open heart surgery.
There are many benefits to robotically-assisted surgery, including:
- Less pain and discomfort
- Minimal scarring
- A lower risk of infection
- A quicker return to normal daily activities
Robotic cardiac surgery is just one way our team of specialists provides innovative cardiovascular care to patients from across the region.
About Lankenau Heart Institute
The Lankenau Heart Institute is Main Line Health’s premier, comprehensive cardiovascular medicine and surgery program. The Lankenau Heart Institute brings together the clinical expertise of all four Main Line Health acute care hospitals and many community cardiology practices to ensure that patients receive a level of quality, service and experience that is unprecedented in the region. Through the systemwide coordination of services, the Lankenau Heart Institute delivers preventive, diagnostic, therapeutic and rehabilitative cardiovascular services at each of our locations including Lankenau Medical Center, Bryn Mawr Hospital, Paoli Hospital and Riddle Hospital.
With a collaborative team of expert consultative cardiologists, interventional cardiologists, electrophysiologists, cardiovascular surgeons and specially trained nurses and technologists, the Lankenau Heart Institute is dedicated to managing and treating patients with heart failure, aortic disease, coronary and peripheral vascular disease, heart rhythm disorders and valve disease. Our team of cardiologists and cardiac specialists provide patients and their families with expert cardiac care, close to home.